Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Pharmacogenetics of Arylamine N-acetyltransferase genes in South African populations
Thesis (PhD)--Stellenbosch University, 2012.
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | en_ZA |
| Published: |
Stellenbosch : Stellenbosch University
2012
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867614111599165440 |
|---|---|
| access_status_str | Open Access |
| author | Werely, Cedric J. |
| author2 | Van Helden, Paul J. |
| author_browse | Van Helden, Paul J. Werely, Cedric J. |
| author_facet | Van Helden, Paul J. Werely, Cedric J. |
| author_sort | Werely, Cedric J. |
| collection | Thesis |
| dc_rights_str_mv | Stellenbosch University |
| description | Thesis (PhD)--Stellenbosch University, 2012. |
| format | Thesis |
| id | oai:scholar.sun.ac.za:10019.1/71832 |
| institution | Stellenbosch University (South Africa) |
| language | en_ZA |
| last_indexed | 2026-06-10T12:46:50.651Z |
| license_str | Other — see source repository |
| provenance_str_mv | Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository |
| publishDate | 2012 |
| publishDateRange | 2012 |
| publishDateSort | 2012 |
| publisher | Stellenbosch : Stellenbosch University |
| publisherStr | Stellenbosch : Stellenbosch University |
| record_format | dspace |
| source_str | SUNScholar — Stellenbosch University Repository |
| spelling | oai:scholar.sun.ac.za:10019.1/71832 Pharmacogenetics of Arylamine N-acetyltransferase genes in South African populations Werely, Cedric J. Van Helden, Paul J. Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Biomedical Sciences. Molecular Biology and Human Genetics. Tuberculosis (TB) -- Diagnosis -- South Africa Drug metabolising enzymes and tuberculosis Genotypic analyses Theses -- Molecular biology Dissertations -- Molecular biology Theses -- Genetics Dissertations -- Genetics Tuberculosis -- South Africa -- Prevention Biomedical Sciences Thesis (PhD)--Stellenbosch University, 2012. Includes bibliography ENGLISH ABSTRACT: Tuberculosis (TB) has been declared a global health emergency by the World Health Organisation, and consequently there is an urgency to develop improved methods of diagnosis and treatment. Despite the current TB epidemic, the disease can be treated effectively using isoniazid (INH) in combination with other antibiotics. However, INH is inactivated in the body by certain drug metabolising enzymes, which may reduce the efficacy of TB treatment. The activity of these drug metabolising enzymes, called NAT, are in turn reduced by nucleotide changes (SNPs) in the gene. These genetic variants (alleles) have been correlated with the rapid- (FA), intermediate- (IA), and slow acetylation (SA) enzymatic activity, and one is therefore able to investigate potential phenotypic effects via genotypic analyses. We investigated these genetic changes in the NAT1 and NAT2 genes in individuals from the local Coloured community (SAC) since this group has one of the highest TB incidences in the country. NAT2 is primarily responsible for the inactivation of INH, whilst NAT1 metabolises para-aminosalicyclic acid (PAS) which is used in the treatment of drug resistant TB. The NAT2 results indicated that the NAT2 alleles were not equally represented in three local ethnic groups studied, and subsequently the rapid, intermediate and slow acetylation activity reflected these differences. However, the relative frequency of these variants in the SAC and Caucasian groups were relatively low. These differences require further investigation to determine their overall relevance to the NAT2 activity differences between groups. In the case of the NAT1 analysis we also observed differences in the relative frequency of various NAT1 alleles between Caucasian and SAC individuals. However, many of these NAT1 SNPs and alleles have not as yet been characterised, so effects of these variants are currently unknown. Interestingly, the NAT1*4 and NAT1*10 alleles were the most prevalent NAT1 alleles in both Caucasians and SAC. The NAT1*4 allele exhibits the rapid NAT1 activity, whilst the activity of the NAT1*10 allele is currently subject to ongoing debate. In this respect, the analysis of NAT1 continues to be a topic for ongoing research. These results, observed for the NAT genes, underscore the importance of doing genetic analyses in local ethnic groups, since these differences may vary significantly between the groups. AFRIKAANSE OPSOMMING: Tuberkulose (TB) is deur die Wêreldgesondheidsorganisasie (WGO) tot 'n globale gesondheidsnood verklaar en derhalwe is dit noodsaaklik dat nuwe, verbeterde diagnostiese metodes ontwikkel word, wat tot meer effektiewe behandeling kan lei. Ten spyte van die huidige TB-epidemie, kan die siekte doeltreffend behandel word deur middel van isoniasied (INH), in kombinasie te met ander antibiotika. INH kan egter geïnaktiveer word deur sekere ensieme in die liggaam, met die gevolg dat INH nie meer effektief is nie in die behandeling van TB. Die aktiwiteit van hierdie ensiem, die sogenaamde NAT2 (Arielamien N-asetieltransferase 2) ensiem, word op sy beurt beïnvloed deur sekere nukleotied veranderings (SNPs) in die geen. Hierdie genetiese veranderings gekorreleer met ensiemaktiwiteitsveranderings (geklassifiseer as vinnig (FA) Intermediêr (IA) en stadig (SA)), wat mens in staat stel om potensiële fenotipiese effekte te ondersoek deur middel van genotipiese analise. Ons het hierdie genetiese veranderings ondersoek in die NAT1 en NAT2 gene in individue van die Kleurling-gemeenskap (SAC) omdat díe bevolkingsgroep die hoogste voorkoms van TB in die land het. NAT2 is primêr verantwoordelik vir die inaktivering van INH, terwyl NAT1 para-amienosalisilaat (PAS) inaktiveer, wat gebruik word in die behandeling van midel-weerstandige TB. Die NAT2 resultate dui daarop dat die allele van die NAT2 geen nie eweredig verteenwoordig wasin die drie etniese groepe nie en derhalwe word die vinnige (FA), intermediêre (IA) en stadige (SA) ensiemaktiwiteite deur hierdie verskille weerspieël. Hoewel die teenwoordigheid van hierdie variante relatief laag was in die SAC en Koukasiër gemeenskappe, is verdere studies nodig om die omvang van hierdie verskille te bepaal ten onsigte van NAT2 aktiwiteit tussen groepe. In die geval van die NAT1 analise het ons verskille waargeneem in die voorkoms van verskeie NAT1 allele tussen Koukasiese en SAC individue. Baie van hierdie NAT1 SNPs is egter nog nie gekarakteriseer nie, en derhalwe is die effek van hierdie NAT1 variante onbekend. Die NAT1*4 en NAT1*10 allele was die prominentste NAT1 alleel in beide Koukasiërs en SAC. Die NAT1*4 is betrokke by vinnige NAT1 aktiwiteit, terwyl die effek van die NAT1*10 alleel nog onderhewig is aan aktiefwe debat. In hierdie verband, is die studie van NAT1 steeds 'n onderwerp vir toekomstige navorsing. Hierdie resultate, wat vir die NAT gene waargeneem is, beklemtoon die belangrikheid van verdere genetiese analises in plaaslike etniese groepe, aangesien hierdie verskille beduidend kan wees tussen die verskillende groepe. Doctoral 2012-11-26T10:23:27Z 2012-12-12T08:13:30Z 2012-11-26T10:23:27Z 2012-12-12T08:13:30Z 2012-12 Thesis http://hdl.handle.net/10019.1/71832 en_ZA Stellenbosch University xvi, 236 p. : col. ill. application/pdf Stellenbosch : Stellenbosch University |
| spellingShingle | Tuberculosis (TB) -- Diagnosis -- South Africa Drug metabolising enzymes and tuberculosis Genotypic analyses Theses -- Molecular biology Dissertations -- Molecular biology Theses -- Genetics Dissertations -- Genetics Tuberculosis -- South Africa -- Prevention Biomedical Sciences Werely, Cedric J. Pharmacogenetics of Arylamine N-acetyltransferase genes in South African populations |
| title | Pharmacogenetics of Arylamine N-acetyltransferase genes in South African populations |
| title_full | Pharmacogenetics of Arylamine N-acetyltransferase genes in South African populations |
| title_fullStr | Pharmacogenetics of Arylamine N-acetyltransferase genes in South African populations |
| title_full_unstemmed | Pharmacogenetics of Arylamine N-acetyltransferase genes in South African populations |
| title_short | Pharmacogenetics of Arylamine N-acetyltransferase genes in South African populations |
| title_sort | pharmacogenetics of arylamine n acetyltransferase genes in south african populations |
| topic | Tuberculosis (TB) -- Diagnosis -- South Africa Drug metabolising enzymes and tuberculosis Genotypic analyses Theses -- Molecular biology Dissertations -- Molecular biology Theses -- Genetics Dissertations -- Genetics Tuberculosis -- South Africa -- Prevention Biomedical Sciences |
| url | http://hdl.handle.net/10019.1/71832 |
| work_keys_str_mv | AT werelycedricj pharmacogeneticsofarylaminenacetyltransferasegenesinsouthafricanpopulations |